Evidence map›Paper›PMID 30612416›Full record

ReviewThe Korean journal of internal medicine2019

Update on heart failure management and future directions.

Hong-Mi Choi, Myung-Soo Park, Jong-Chan Youn

Erratum issuedOpen access · goldAbstract readReview
In one paragraph

Review in The Korean journal of internal medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 59 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
59citing papers in PubMed, 1 pooled it
6.2field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

59 citing papers in PubMed, 1 synthesis or guideline pooled it, 114 citations in OpenAlex.

  1. Pooled it
  2. A comparative analysis of echocardiographic data for heart transplant eligibility in brain death cases.The Egyptian heart journal : (EHJ) : official bulletin of the Egyptian Society of Cardiology · 2025
    Article
  3. Article
  4. Article
  5. Article
  6. History of Heart Failure Definition.Cardiac failure review · 2025
    Review
  7. Article
  8. Observational
  9. Article
  10. Article
  11. Article
  12. Microbiology spectrum · 2024
    Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Hong-Mi ChoiDivision of Cardiology, Hallym University Sacred Heart Hospital, Anyang, Korea.
Myung-Soo ParkDivision of Cardiology, Hallym University Dongtan Sacred Heart Hospital, Hwaseong, Korea.
Jong-Chan YounDivision of Cardiology, Hallym University Dongtan Sacred Heart Hospital, Hwaseong, Korea.
Hallym University Dongtan Sacred Heart Hospital · KRHallym University Sacred Heart Hospital · KR

Funding

Ministry of Science, ICT and Future PlanningNational Research Foundation of Korea 2018R1C1B6005448
6 · The paper itself

Abstract

Heart failure (HF) is an important cardiovascular disease because of its increasing prevalence, significant morbidity, high mortality, and rapidly expanding health care cost. The number of HF patients is increasing worldwide, and Korea is no exception. There have been marked advances in definition, diagnostic modalities, and treatment of HF over the past four decades. There is continuing effort to improve risk stratification of HF using biomarkers, imaging and genetic testing. Newly developed medications and devices for HF have been widely adopted in clinical practice. Furthermore, definitive treatment for end-stage heart failure including left ventricular assist device and heart transplantation are rapidly evolving as well. This review summarizes the current state-of-the-art management for HF and the emerging diagnostic and therapeutic modalities to improve the outcome of HF patients.

Indexed as

BiomarkersCardiac Imaging TechniquesCardiovascular AgentsFemaleGenetic TestingGenetic TherapyHeart-Assist DevicesHeart FailureHeart TransplantationHumansMalePrognosisRepublic of KoreaRisk FactorsStem Cell TransplantationBiomarkersCardiovascular AgentsDiagnosisHeart failureManagementPrognosis

Identifiers

PMID30612416
PMCPMC6325445
OpenAlexW2907497617

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.